Stuart Duty - 28 Aug 2024 Form 4 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MIST	Stock Option (right to buy)	Award	$0	+40,000		$0.000000	40,000	28 Aug 2024	Common Shares	40,000	$1.45	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	This option will vest in twelve (12) equal monthly installments, beginning on September 28, 2024, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date.